These results show that NK cells from newly diagnosed patients with RRMS have increased percentages of the inhibitory KLRG1+ within the most immature NK cells subset and increased percentages of the activating NKp30+ within the most mature NK cells subset. The gene discussed is NCR3; the disease is relapsing-remitting multiple sclerosis.